Publications
54
Citations
702
Est. group size
—
Recurring co-author estimate
Active years
10
Publishing since 2017
Emma K. Grant works in chemical biology and medicinal chemistry, developing small molecules that bind to and inhibit disease-relevant proteins. A major focus is covalent drug discovery (drugs that form a permanent chemical bond with their target), including rapid 'direct-to-biology' screening methods, along with chemical probes for imaging cancer cells and inhibitors of cancer-related enzymes such as WRN helicase.
Publication activity has grown over the last decade, with a notable peak in 2024 and a recent average of about 7 papers per year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Table S1 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2026
- Table S3 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2026
- Table S2 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2026
- Druggability is not static
Nature Chemical Biology · 2026
- Next Generation Sulfonyl Fluoride Electrophiles Expand the Scope of Covalent Drug Discovery
ChemRxiv · 2026
- A chemical probe for prostate-specific membrane antigen for real-time Raman imaging of prostate cancer cells
Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) · 2026
- Author response for "Emerging applications of stimulated Raman scattering microscopy for medicinal chemistry and drug discovery"
2025
- Author response for "Emerging applications of stimulated Raman scattering microscopy for medicinal chemistry and drug discovery"
2025
- Emerging applications of stimulated Raman scattering microscopy for medicinal chemistry and drug discovery
Chemical Society Reviews · 2025
- ‘Direct-to-biology’ drives optimisation of a cell-active covalent inhibitor of WRN helicase
ChemRxiv · 2025
- Expedited SARS-CoV-2 main protease inhibitor discovery through modular ‘direct-to-biology’ screening
ChemRxiv · 2024
- Data from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2024
- Table S1 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2024
- Table S2 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2024
- Table S3 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2024
- ChemRxiv×8
- Angewandte Chemie International Edition×4
- Angewandte Chemie×4
- DNA repair×2
- ACS Chemical Biology×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile